Moxifloxacin, For Chemical, Pharmaceutical

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by bayer ag (initially called bay 12-8039). It is marketed worldwide (as the hydrochloride) under the brand names avelox, avalox, and avelon for oral treatment. In most countries, the drug is also available in parenteral form for intravenous infusion. Moxifloxacin is also sold in an ophthalmic solution (eye drops) under the brand names vigamox, moxeza for the treatment of conjunctivitis (pink eye).